Unit of Vaccinology, Pediatric Infectious Disease Epidemiology, and Pharmacoepidemiology

Since 2012, this unit has randomized over 11,000 infants in investigator-initiated vaccine trials, showcasing unmatched expertise in clinical trials and vaccine research. Their multifaceted approach includes clinical trials with integrated lab work, national real-life vaccine efficacy and safety cohort studies, and pharmacoepidemiological evaluations of long-term safety for biologicals.